Summary
- Profile Type
- Technology request
- POD Reference
- TRDK20240912003
- Term of Validity
- 12 September 2024 - 12 September 2025
- Company's Country
- Denmark
- Type of partnership
- Research and development cooperation agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- A Danish Start-Up has developed and patented a novel Oral drug delivery concept based on natures materials and demonstrated experimentally the reproducible delivery properties of the gastro-resistant encapsulation material. This material can be used for oral delivery of Nutraceuticals and Biopharmaceuticals to the intestine of humans as well as mammals (pigs, dogs, cats and others).The company is looking for a development partner with experience in enzymes and forming dietary fibers.
- Full Description
-
A Danish company has invented a novel oral drug delivery concept based on dietary fibers and their digesting enzymes. The ingredients contrary to other marketed gastro-resistant delivery platforms is based on food-grade ingredients. The company has performed the background research showing that its composite system has a reproducible release profile, which we can robustly engineer to deliver anywhere in the late small intestine and the large intestine (colon). The reproducibility suggests that it can provide better delivery statistics than existing oral delivery methods and thus improve the provable efficacy of nutraceuticals and so lift such products to a higher value category.
The company is seeking a business partner which can collaborate on finalizing the capsule production process and ideally has a nutraceutical needing an effective encapsulation. - Advantages and Innovations
- The encapsulation is made from food-grade ingredients and so does not impose any restrictions on the dose. This solves a problem with the existing gastro-resistant encapsulations which either have a limited daily intake due its potential adverse effect or do not provide a reliable targeted delivery.
- Stage of Development
- Under development
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- IPR description
- The company is looking for industrial partners with experience in enzymes and bacterial cellulose and preferably also have one or more nutraceutical to be encapsulated by an effective Gastro-resistant enteric encapsulation.
Partner Sought
- Expected Role of a Partner
- The partner company is expected to provide industrial experience in enzymes and bacterial cellulose and preferably also have one or more nutraceutical to be encapsulated by an effective Gastro-resistant enteric encapsulation.
- Type and Size of Partner
- SME 50 - 249
- SME 11-49
- Big company
- Type of partnership
- Research and development cooperation agreement
Dissemination
- Technology keywords
- 03004006 - Organic Substances
- 03004001 - Agro chemicals
- 03004007 - Pharmaceutics
- 06001012 - Medical Research
- 06001015 - Pharmaceutical Products / Drugs
- Market keywords
- 05007002 - Pharmaceuticals/fine chemicals
- 05009003 - Animal health
- 05005022 - Other clinical medicine
- Sector Groups Involved
- Health
- Agri-Food
- Targeted countries
- All countries